Abstract Ischemic stroke and ischemia/reperfusion (I/R) injury induced by thrombolytic therapy are conditions with high mortality and serious long-term physical and cognitive disabilities. They have a major impact on global public health. These disorders are associated with multiple insults to the cerebral microcirculation, including reactive oxygen species (ROS) overproduction, leukocyte adhesion and infiltration, brain blood barrier (BBB) disruption, and capillary hypoperfusion, ultimately resulting in tissue edema, hemorrhage, brain injury and delayed neuron damage. Traditional Chinese medicine (TCM) has been used in China, Korea, Japan and other Asian countries for treatment of a wide range of diseases. In China, the usage of compound TCM preparation to treat cerebrovascular diseases dates back to the Han Dynasty. Even thousands of years earlier, the medical formulary recorded many classical prescriptions for treating cerebral I/R-related diseases. This review summarizes current information and underlying mechanisms regarding the ameliorating effects of compound TCM preparation, Chinese materia medica, and active components on I/R-induced cerebral microcirculatory disturbances, brain injury and neuron damage.
Introduction
Stroke is the second leading cause of mortality in the world, resulting in 6,671,000 deaths (11.9% of all deaths) in 2012 1 . Pathogenically, ischemic stroke caused by vessel occlusions accounts for 85% of all conditions. Since the core of brain tissue undergoes necrotic cell death within a few minutes of the onset of cerebral ischemia, early restoration of blood flow by thrombolytic therapy decreases morbidity and mortality in these patients 2 . Paradoxically, reperfusion itself evokes additional injury to ischemic penumbra, a region bordering the infarct core, causing the so-called ischemia-reperfusion (I/R) injury. Such injury exacerbates brain damage, leading to increases in severe morbidity in surviving victims. I/R imposes multiple insults to the cerebral microcirculation, including reactive oxygen species (ROS) outburst, inflammatory mediator overproduction, leukocyte infiltration, microvessel hyperpermeabilty, brain blood barrier (BBB) disruption, capillary hypoperfusion, etc. Many of these factors are thought to play significant roles in the pathogenesis of post-ischemic injury in stroke patients 3 . Much effort has been made to attenuate the microcirculatory disturbances by ablating a single factor in the pathogenesis, including introduction of recombinant tissue plasminogen activator (rtPA) 4, 5 , antioxidants 6 , anti-intercellular adhesion molecule-1 (ICAM-1) antibody 7 , calcium-stabilizing agents 8 and anti-excitotoxic agents 9 . However, clinical trials have failed to show positive effects in patients with ischemic stroke. Other therapeutic approaches, such as anti-inflammatory 10 and anti-apoptotic 11 agents, are being evaluated, but no successful clinical trials have thus far been reported. These results suggest that such microcirculatory disturbances are part of a complicated pathological process involving multiple, coordinated events. Once initiated, the process may only be interrupted by a remedy consisting of multiple compositions that target the underlying insults.
For more than two thousand years, traditional Chinese medicine (TCM) has been used in China, Korea, Japan and other Asian countries for the clinical treatment of cerebrovascular diseases including stroke, encephalitis, dizziness, insomnia, amnesia, and dementia. In China, the use of compound TCM preparations to treat cerebrovascular diseases dates back to the Han Dynasty. "Treatise on Cold Damage (Shang Han Lun)" and "Synopsis of the Golden Chamber (Jin Kui Yao Lue)" appeared at that time which recorded several classical formulas, including Chaihu Jia Longgu Muli Tang, Guizhi Fuling Wan, Gualou Guizhi Tang, and others, which were devoted to cope with cerebrovascular diseases. In the Tang dynasty, medical formulas were further developed, as shown by "Important Prescriptions Worth a Thousand Gold for Emergency (Qian Jin Fang)" and "Arcane Essentials from the Imperial Library (Wai Tai Mi Yao)"; these documented the use of Xiaoxuming Tang, Dihuang Yinzi and Huanglian Jiedu Tang for the treatment of cerebrovascular diseases.
In the dynasties that followed, more compound TCM preparations were used in clinic. In the Song dynasty, treatments included Sijunzi Tang and Longdan Xiegan Tang, documented from "Formulary of the Bureau Taiping People's Welfare Pharmacy (Tai Ping Hui Min He Ji Ju Fang)". In the Yuan dynasty, medicines included Shengmai San, as reported in "Revelation of Medicine (Yi Xue Qi Yuan)". In the Jin dynasty, the use of Chaihu Shugan San was mentioned in "Jing-Yue's Collected Works (Jing Yue Quan Shu)". Finally, in the Qing dynasty, Buyang Huanwu Tang and Taohong Siwu Tang were used according to "Correction on Errors in Medical Works (Yi Lin Gai Cuo)" and "Golden Mirror of the Medical Ancestors (Yi Zong Jin Jian)", respectively.
Nowadays in China, several new compound TCM preparations have been formulated for the treatment of cerebrovascular diseases. Based on classical formulas and approved by the State Food and Drug Administration (SFDA), these include Cerebralcare Granule s (Yangxue Qingnao granule), Tongxinluo capsule, Shenfu injection, Danhong injection, Huatuo Zaizao extractum. The name, composition and origin of the compound TCM preparations that are derived from TCM literatures or approved by the SFDA and cited in the present review are listed in Table 1 . In addition, Chinese materia medica as well as active ingredients and components included in compound TCM preparations are listed in Table 2 . These represent substances of recent research interest as related to their possible roles in the pathogenesis of I/R-induced brain injury, neuron damage and the underlying mechanisms. The present review is based on 139 references published from 1995 to 2014, mainly focusing on the ameliorating effects and underlying mechanisms of TCM preparations, Chinese materia medica, and active compounds on I/R-induced cerebral microcirculatory disturbances, brain and neuron damage. Ameliorating effects of traditional Chinese medicine preparation2. Effects of TCM preparation, Chinese materia medica, and active compounds on pathogenesis of cerebral microcirculatory disturbances induced by I/R
Oxidative stress
Significant amounts of ROS are generated during cerebral I/R, which are widely regarded as the initial step in brain damage after stroke. Numerous clinical and experimental observations have shown increased ROS formation during all forms of stroke injury. ROS are highly active and able to react with DNA, protein, and lipid directly, causing damage and dysfunction of the molecules to various degree 48 . The primary source of ROS during I/R injury is the mitochondria, which produce superoxide anion radicals during the electron transport process. Other potentially important sources of ROS include xanthine oxidase, cyclooxygenase, lipooxygenase, and others, depending on cell types. Oxygen free radicals can also be generated by activated microglia and infiltrating leukocytes via the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase pathway following reperfusion 49 . In recent studies, researchers found that some compound TCM preparations, Chinese materia medica and active components produce positive effects on cerebrovascular diseases partially due to their antioxidant properties. Using dihydrorhodamine 123 (DHR), a hydrogen peroxide-sensitive mitochondrial probe, researchers demonstrated in vivo that compound TCM preparations, such as Cerebralcare Granule s attenuates DHR fluorescence intensity in gerbil cerebral microvessels, in either the early phase (60 min) or late phase (5 days) of reperfusion after global ischemia 50, 51 . The single active component notoginsenoside R1 was found to prevent oxidative stress by suppressing both mitochondrial and NADPH oxidase-dependent superoxide generation and inhibiting production of malondialdehyde (MDA), protein carbonyl, and 8-hydroxydeoxyguanosine (8-OHdG) in rat with middle cerebral artery occlusion (MCAO) and reperfusion in vivo 34 . This compound also had antioxidant activity in primary cortical neurons stimulated by oxygen-glucose deprivation (OGD) followed by reoxygenation in vitro 34 . Other compound TCM preparations, such as Yiqi Tongluo Jiedu capsule 52 , as well as several active components from Chinese materia medica (including total glycoside from Chishao, Radix Paeoniae Rubra 53 , astragaloside 13, 14 , and tetrahydroxystilbene glucoside 46 ) alleviated ROS production in cerebral tissue via inhibiting inducible nitric oxide synthase (iNOS) activation and nitric oxide (NO) overproduction. Other experiments reported that Chinese materia medica Danshen (Radix Salviae Miltiorrhizae) 54 and active component baicalin 19 exert their antioxidant effect by lowering adenosine metabolites hypoxanthine and inhibiting cyclooxygenase, respectively. In addition to ROS source regulation, TCM preparation, Chinese materia medica and active compounds ameliorate I/R-induced oxidative stress by scavenging free radicals directly or by modulating tissue antioxidant potency. In a recently published study, three classical formulas (Huanglian Jiedu Tang, Chaihu Jia Longgu Muli Tang, and Guizhi Fuling Wan) showed scavenging activity for free-radical superoxide anion radicals, hydroxyl radicals and 1,1-diphenyl-2-picrylhydrazyl radical 2,2-diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl (DPPH), respectively, while suppressing lipid peroxidation 55 . Another study reported that the single active component salvianolic acid A reduces the MDA contents in the cortex, hippocampus and corpus striatum in I/R rat brain, which may also attribute to its scavenging effect on free hydroxyl radicals in vitro 38 . Shengmai San, another classical formula, improved oxidative damage manifested as suppression of MDA and thiobarbituric acid reactive substance (TBARS) formation and increased superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities in brain tissues from rodent global or MCAO models. This treatment was active whether given before ischemia or after re-perfusion [56] [57] [58] . In parallel, aqueous or ethanolic extract from Baihuasuantengguo (Embelia ribes Burm) increased the glutathione (GSH), GSH-Px, glutathione reductase and glutathione-S-transferase levels in both hippocampus and frontal cortex with decreases in lactate dehydrogenase (LDH) level in serum and TBARS levels in hippocampus and frontal cortex in rat after MCAO 59, 60 . Lavender oil was also found to reduce the levels of mitochondria-generated ROS, MDA and carbonyl, and to upregulate the ratio of GSH/glutathione disulfide (GSSG), the activities of SOD, catalase (CAT) and GSH-Px in brain tissue after focal ischemia 61 . Similar antioxidant effects have been reported for some other TCM preparation, such as Tongxinluo capsule 62 , Yimucao (Herba Leonuri) injection 63 , and active components, such as Yinxing (Folium Ginkgo) extract 64 , paeonol 35 and 3 0 -methoxy-puerarin 12 .
Inflammatory mediators
Inflammation is increasingly recognized to be the key element in the pathological progression of ischemic stroke, as early inflammatory responses may potentiate reperfusion injury in post-ischemic brain tissue. There are several resident cell populations within brain tissue that are able to secrete proinflammatory mediators after an ischemic insult, including endothelial cells, leukocytes, astrocytes, microglia and neurons. Activation of transcription factors via nuclear factor κ-B (NF-κB), mitogen activated protein kinase (MAPK), and activator protein-1 (AP-1) inflammatory signaling pathway causes an increased production of cytokines, chemokines, adhesion molecules and other proinflammatory mediators 65 . Several agents that can regulate inflammatory mediators or transcription factors reduce infarct size and neurological deficits following focal stroke in rodents; such treatments are considered to be an alternative therapeutic approach in stroke patients 66 . In this regard, Guizhi Fuling capsules, a classical formula, were reported to down-regulate the expression of pro-inflammatory cytokines [including interleukin-1β (IL-1β) and tissue necrosis factor-α (TNF-α)] and markedly up-regulate the expression of antiinflammatory cytokines interleukin-10 (IL-10) and IL-10 receptor at both mRNA and protein levels in rats with focal cerebral I/R. The serum levels of these inflammatory cytokines were regulated in the same way 67 . In other in vivo MCAO experiments, TCM Naomaitong preparation 68 and the single active component tetrandrine 47 have proven to decrease the expression and mRNA level of TNF-α, vascular adhesion molecule-1 (VCAM-1), ICAM-1 in brain tissue 1 or 3 days after reperfusion, partly due to suppressing NF-κB activation. Similar results were found for TCM preparations, such as Taohong Siwu Tang 69 , FBD formula [a herbal formula composed of Fuling (Poria), Baizhu (Rhizoma Atractylodis Macrocephalae) and Danggui (Radix Angelicae Sinensis)] 70 , as well as Chinese materia medica Danshen (Radix Salviae miltiorrhizae) aqueous extract 71 . A broad spectrum of cytokines and chemokines were abrogated by treatment with these TCM, including high-sensitivity C-reactive protein (hs-CRP), hypoxiainducible factor (HIF)-1α, IL-1β, interleukin-8 (IL-8), TNF-α, iNOS levels in serum or brain, and TNF-α mRNA and transforming growth factor β1 (TGF-β1) expression in cerebral tissue; these effects were partly due to down-regulation of cerebral Inhibitory-κB-α (I-κBα) and NF-κB phosphrylation 70 . In a global cerebral ischemia model, treatment with the single active component resveratrol before insult reduced astroglial and microglial activation as well as cyclooxygenase-2 (COX-2) and iNOS expression 7 days after I/R. These effects were attributed to suppression of NF-κB and Jun N-terminal kinase (JNK) activation 36 . In addition to in vivo results, in vitro experiments demonstrated that another active component honokiol reduced TNF-α and NO level in the primary cultured microglia medium and in the microglia and astrocytes co-culture medium. Also, honokiol was shown to decrease the level of RANTES (regulated upon activation normal T-cell expressed and secreted) protein in medium of microglia or astrocytes, which was related to its effect on microglia NF-κB p65 nuclear translocation 28 .
Leukocyte infiltration
A growing body of evidence indicates that recruitment of leukocytes contributes to the initiation and evolution of brain injury after ischemic stroke. The adhesion and migration of neutrophils is evident in cerebral venules from several minutes to a few hours following reperfusion. The population of recruited cells shifts from polymorphonuclear (PMN) to mononuclear leukocytes and lymphocytes, and leukocyte recruitment persists for days to weeks following ischemia 72, 73 . Rodents with reduced PMN or T-lymphocyte accumulation show reduced infarct volumes and improved neurological outcomes. Prevention of leukocyte-endothelial cell adhesion with adhesion molecule antibodies also protects against stroke injury 74 . In a rat MCAO model, leukocyte adhesion was observed continuously in cerebral microvessels by infusion of rhodamine 6G, and the number of adherent leukocytes after I/R increased immediately and remained increased during 60 min after reperfusion. Pretreatment with TCM preparation Cerebralcare Granule s attenuated this I/R-elicited enhancement of leukocyte adhesion; the effects of the higher dose (0.8 g/kg) were more significant than those following the lower dose (0.4 g/kg) 75 . Consistently, Cerebralcare Granule s inhibited leukocyte adhesion either during the early phase (60 min) or in the late phase (5 days) of reperfusion after global ischemia in gerbils 50, 51 . Using 51 Cr-labeled neutrophil, researchers also demonstrated that tetrandrine decreased neutrophils recruitment in brain tissue 24 h after reperfusion in rat with MCAO 47 . The classic formula Huanglian Jiedu Tang and its constituents inhibited myeloperoxidase (MPO) activity, an indication of neutrophil infiltration, in ischemic brain tissue by 30% after focal I/R 76 . The same result was observed when using other TCM preparations, such as Shengmai San 56 , Tongxinluo capsule 77 , and Chinese materia medica Zhimu (Rhizoma Anemarrhenae) 78 , either in rodent global or focal I/R injury. FBD formula inhibited PMNs infiltration in ICR mouse brain subjected to repetitive 10 min of common carotid arteries occlusion followed 24 h reperfusion, and in vitro results showed that FBD formula could inhibit TNF-α-triggered PMNs adhesion to ECV304 endothelial cells 70 . In another in vitro experiment, the single active compound salvianolic acid A was proven to inhibit the adherence of granulocytes on brain microvascular endothelial cells (BMEC); the effect was attributed to decreasing the expression of ICAM-1 on BMEC at the gene and protein levels 39 .
Brain blood barrier (BBB) disruption
BBB consists of microvascular endothelial cells, basal lamina, pericytes and astrocyte endfeet. Microvessel hyperpermeability disrupts the normal BBB function during cerebral I/R injury. Microvessel permeability is regulated by both paracellular and transcellular pathways 79 . Paracellular pathways are mainly governed by tight junctions; the loss of tight junction integrity occurs and directly contributes to cerebral BBB disruption under ischemic stroke conditions 80 . An alternative mechanism for BBB opening involves upregulation of caveolae, including the expression and phosphorylation of the structural component caveolin-1 (Cav-1), as demonstrated by transmission electron microscopy in endothelial cells in several stroke models 81 . In a rat MCAO model, recent in vivo studies found that both pre-and post-treatment with the TCM preparation Cerebralcare Granule s reduces FITC-labeled albumin leakage from cerebral venules evoked by I/R, in either the early or late phase after reperfusion 75, 82 ; the same results were found in a gerbil global I/R model 50, 51 . Further study using confocal microscopy revealed that the continuous distributions of tight junction proteins including claudin-5, occludin, junctional adhesion molecule-1 (JAM-1) and zonula occludens-1 (ZO-1) were disrupted after reperfusion for 3 h and 6 days, concomitant with reduced immune staining. Western blotting indicated the degradation of tight junction proteins in response to I/R. Interestingly, these losses in structural integrity were reversed by Cerebralcare Granule s treatment. In addition, I/R-induced increases in the cytoplasmic caveolae of capillary endothelial cells and cerebral Cav-1 expression were both down-regulated by Cerebralcare Granule s , as observed by electron microscopy and
Western blotting, respectively. Taken together, these findings suggest involvement of both the paracellular and transcellular pathways in the beneficial effects of Cerebralcare Granule s on BBB disruption following cerebral I/R injury 82 . Similarly, treatment with the TCM preparation Tongxinluo capsule increased ZO-1 and occludin expression in cerebral microvessels 24 h after MCAO in mice 77 . In addition, enzymatic degradation of the extracellular matrix by matrix metalloproteinases (MMPs), secretion of vascular endothelial growth factor (VEGF), ROS production, leukocyte infiltration, and inflammatory mediator release within the ischemic core or peri-infarct area have all been postulated to trigger BBB disruption directly or indirectly during I/R process. To this end, TCM preparations such as naomaitong preparation 83 , and Panax notoginseng saponins combined with astragaloside 15 , were reported to protect against cerebral microvessel basement membrane injury via modulating gelatinase system, inhibiting MMP-2 and MMP-9 expression and improving tissue inhibitor of metalloproteinase-1 (TIMP-1) protein level in rodent brain tissue after I/R. Using immunohistochemistry, the single active component salvianolic acid B was shown to alleviate the extravasation of immunoglobulin and attenuate MMP-9 expression induced by cerebral I/R, which was related to the inhibition on p38MAPK activation and extracellular signalregulated kinase (ERK) 1/2 phosphorylation 41 . Other TCM preparations, such as Weinaokang preparation 84 and Huatuo Zaizao extractum 85 , may also effectively recover BBB ultrastructure injury induced by I/R via inhibiting expressions of MMP-2 and MMP-9, which might be associated with reduction of G proteincoupled receptor kinase 2 (GRK2) in membrane translocation and activation. Another experiment showed that aromatic resuscitation drugs have the protection effect on BBB by decreasing the level of VEGF in addition to MMP-9 86 . Besides, the effects of TCM preparation, Chinese materia medica and active compounds on ROS production, leukocyte infiltration and inflammation all contribute to ameliorating BBB disruption to some extent, as discussed above.
Capillary hypoperfusion
It has been known for some time that loss of microvascular patency impairs cerebral vascular re-perfusion following global or focal cerebral ischemia 87 . After reperfusion, adhered leukocytes, entrapped erythrocytes, and fibrin-platelet deposits obstruct capillary lumens. Moreover, swollen astrocyte endfeet, pericyte contraction and microvessel hyperpermeability all contribute to capillary occlusion after reperfusion 88, 89 . A recent clinical study showed that perfusion status, rather than successful recanalization, has a significant impact on the outcome of stroke patients 90 , suggesting that improvement of microcirculatory reperfusion seems to be a promising strategy in stroke patients after thrombolysis. With the use of the intravital microscopy equipped with a high-speed video camera in a rat MCAO model, researchers demonstrated that the number of open capillaries reduced considerably 60 min after reperfusion, and pre-treatment with TCM preparation Cerebralcare Granule s attenuated this alteration 75 . In addition, cerebral blood flow (CBF) in cortex decreased 3 h after I/R, and this reduction remained for 6 days. Cerebralcare Granule s post-treatment after reperfusion attenuated the I/R-evoked decrease in CBF 82 . Consistent with the result observed by intravital microscopy and laser Doppler, transmission and scanning electron microscopy clearly identified that pre-or post-treatment with Cerebralcare Granule s ameliorated cerebral microvasculature changes, including narrowed lumen, rough inner surface, swelling endothelial cells and perivascular astrocyte end feet. The treatment also restored the decrease in the number of open capillaries 24 h or 6 days after reperfusion 75, 82 . Similar results were found when using Cerebralcare Granule s in global I/R injury 50 . Assessment of hemorheology by a full-automatic hemorheolometer revealed that acupoint-injection of compound Angelica-root injection (Fufang Danggui injection) downregulated blood viscosity including high, medium and low shearing rates, erythrocyte aggregation index, and rigidity index; deformity index was up-regulated, facilitating cerebral blood circulation 91 . Other TCM preparations, such as Erigeron injection (Dengzhanhuasu injection) 92 , Astragalus injection (Huangqi injection) 93 , Naosaitong preparation 94 , and icariin combined with P. notoginseng saponins 29 were also reported to improve blood rheology and CBF after cerebral I/R injury. In addition, Gualou Guizhi decoction reduced cerebral ischemic spasticity, improved the screen test and Hoffman's reflex scores, which might be related to modulation of glutamate (Glu) levels and α-amino3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression 95 .
Effects of TCM on brain injury and neuron damage induced by I/R
Within a few minutes of the onset of cerebral ischemia in stroke patients, the core of brain tissue exposed to the most dramatic blood flow reduction is mortally injured, and subsequently undergoes necrotic cell death. The reduction of oxygen and nutrient supply induces a series of metabolic dysfunctions such as reduction in ATP formation and energy failure, loss of cell ion homeostasis, acidosis, membrane depolarization, Ca 2þ influx, excessive release of excitatory amino acids, free radical-mediated toxicity, all resulting in brain and neuron necrosis 96, 97 . Thrombolysis strategies have proven to be the most effective therapies for stroke treatment. However, early reperfusion of ischemic brain tissue can result in harmful consequences, including ROS outburst, overproduction of inflammatory mediators, leukocyte infiltration, microvessel hyperpermeabilty, all of which lead to BBB disruption and capillary hypoperfusion. Ultimately, activation of these cascades culminate in cerebral edema and/or brain hemorrhage and exacerbate brain injury 3 . On the other hand, cerebral microcirculatory disturbances, together with other neurotoxicity mediators such as Na þ , Ca 2þ and Glu, are detrimental to neuronal survival in the ischemic penumbra or peri-infarct zone; apoptotic neuron death is a common outcome 98 .
Effects of TCM on brain injury induced by I/R
As discussed above, TCM has multiple beneficial roles in cerebral I/R-induced microcirculatory disturbances. Among these are positive effects on brain injury, such as brain infarction, perivascular edema and hemorrhage after I/R. In this aspect, HE staining demonstrated a histopathological damage after global or focal cerebral I/R, which could be inhibited by some TCM preparations, such as Shengmai San 56 , Naomaitong preparation 99 and active component baicalin 19, 20 . By virtue of magnetic resonance imaging (MRI), rat brain edema was observed 3 h after MCAO and remained unchanged 6 days after reperfusion. Interestingly, TCM preparation Cerebralcare Granule s reduced cerebral edema even when administered after the initiation of edema 82 . Likewise, scanning electron microscopy revealed swollen glia and edema around cerebral microvessels which were abrogated by Cerebralcare Granule s50,82 and the active component apigenin 18 , after global or focal I/R injury. By means of high performance liquid chromatography (HPLC) and atomic absorption spectrophotometry, the TCM preparation Shenfu injection was found to decrease glutamate and Ca 2þ in brain tissue and reduce excitatory amino acid toxicity, effects which can alleviate tissue edema 100 . Using Evan's blue dye extravasation and/or brain water content assessment, large doses of TCM preparation, Chinese materia medica, and active compounds were demonstrated to restrain BBB disruption and brain tissue edema after I/R, although the mechanisms for the effects of each TCM may differ. For example, combinations of total alkaloids from Gouteng (Ramulus Uncariae cum Uncis) and Xiatianwu (Rhizoma Corydalis Decumbentis) 101 and the active compound sodium tanshinone B 45 were thought to act through anti-oxidation, whereas the TCM preparation Naomaitong preparation 68 and Guizhi Fuling capsules 67 may produce beneficial effects by anti-inflammatory mechanisms. In contrast, FBD formula 70 and Chinese materia medica Zhimu (Rhizoma Anemarrhenae) 78 may act through inhibition of leukocyte infiltration, whereas the TCM preparation Shexiang Xingnaoning preparation 102 as suggested may act by anti-thrombotic mechanisms. Finally, Cerebralcare Granule s82 and Tongxinluo capsule 77 are thought to maintain the BBB. Consistent with anti-edema effects, the beneficial effects of TCM preparations, Chinese materia medica and active compounds on cerebral infarction after I/R injury have also been reported. For example, 2,3,5-triphenyltetrazolium chloride (TTC) staining showed that the TCM preparation Xuezhikang capsule 103 , total flavones of Chinese materia medica Huangshukui (Abelmoschus manihot) 104 , and active compounds, such as calycosin 24 and astrogaloside 16 , inhibited brain infarction mainly by anti-oxidative effect. On the other hand, the classical formula Buyang Huanwu Tang 105 , and TCM preparations, such as Danhong injection 106 , Astragalus injection (Huangqi injection) 93 , and Naosaitong preparation 94 were shown to inhibit cerebral tissue necrosis via promoting blood vessel repair 105 , anticoagulant and antifibrinolytic activity 106 , and improvement of capillary perfusion. In contrast studies on edema and infarction, few studies have been published showing the ameliorating effect of TCM preparations, Chinese materia medica, and active compounds on cerebral hemorrhage induced by I/R injury. However, these medicinals can alleviate intracerebral hemorrhage in some situations, such as surgery 107 , traumatic intracranial hematoma 108 , and artificial cerebral hemorrhage in animal models 109 .
Effects of TCM on neuron damage induced by I/R
A variety of tests are available for evaluation of neurobehavioral function, such as Long's test 33, 43, 93 , Morris water maze test 17, 19, [110] [111] [112] , eight-arm radical maze test 29, 113 , step down and step through test 40, 53 , beam-walking test 42 , forced swimming test and tail suspension test 103 . Using these tests, many TCM preparations, Chinese materia medica and active compounds have been shown to alleviate neurological deficits and improve learning and memory after I/R injury. These include TCM preparations such as Xiaoxuming decoction 112 and Yizhi capsule 110, 111 , and Chinese materia medica such as Sanqi (Radix et Rhizoma Notoginseng) 113 , and Gegen (Radix puerariae) ethanol extract 114 . The list also includes active compounds, such as astrogaloside 17 , salvialonic acid A 40 , salvianolic acid B 42 , morroniside 33 and scutellarin 43 . The underlying mechanism for neuroprotection in each case is distinct. Candidate mechanisms include anti-apoptosis, anti-excitoxicity and pro-neurogenesis. The following sections will discuss each of these separately.
Effects of TCM on apoptosis
Nissl staining and DNA fragmentation assays demonstrated that the TCM preparation Naoshuantong capsule reduced neuronal apoptosis in ischemic cortex and in the hippocampal CA1 region after rat MCAO; neurological functional deficits were also attenuated. Naoshuantong capsule also suppressed the overexpression of Bax and activation of caspases-3, -8 and -9, inhibited the reduction of Bcl-2 expression and depressed the Bax/Bcl-2 ratio 115 . Likewise, Nissl and terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) staining, along with electron microscopic observations, showed that the TCM preparation Cerebralcare Granule s attenuated neuron death in cortex after focal I/R and in hippocampal CA1 region after global I/R. These beneficial effects were partly attributed to improving cerebral microcirculatory disturbances, balancing Bcl-2 superfamily protein expression, and modulation of the PUMA-p53 proapoptotic pathway 51, 75 . Staining with hematoxylin and eosin (HE), TUNEL and Hoechst 33258 was used to show that the classical formula Dihuang Yinzi 116 , the TCM preparation Astragalus injection (Huangqi injection) 93 , and active compounds, such as astragalosides 17 and tetrahydroxystilbene glucoside 46 attenuated neuronal apoptosis. Mechanisms for these actions include ERK activation, inhibition of JNK phosphorylation, and up-regulation of Akt phosphorylation; this last mechanism may also be important in the neuroprotective effect of eupatilin 25 and resveratrol 37 . Other active compounds, such as Leonurine 30 and ginsenoside Re 26 were reported to attenuate I/R-induced mitochondrial swelling, reverse changes in mitochondrial membrane potential, and restore cytochrome c levels in mitochondria. The antiapoptotic actions of these preparations were suggested to contribute to these effects. Another experiment found that the active compound scutellarin alleviated mitochondrial dysfunction through inhibition of poly-ADP-ribose polymerase (PARP) overactivation and the subsequent translocation of apoptosis inducing factor (AIF) from mitochondria to nuclei following cerebral I/R 43 . Other TCM preparations, such as Buyang Huanwu decoction 117 , Xingnaojing plus Xuesaitong injection 118 , Naoshuantong capsule 119 , Yinxing (Folium Ginkgo) extract 120 , and active compounds, such as ginsenoside Rg3 27 and lycopene 32 displayed similar neuroprotective actions via anti-apoptotic effects.
Effects of TCM on excitoxicity
Excitatory amino acids accumulate in the extracellular space following ischemia and activate their receptors, leading to intracellular Ca 2þ overload followed by neuronal damage. HPLC results demonstrated that the classical formula Buyang Huanwu decoction 121 , Tianma Gouteng Fang 122 , and Chinese materia medica Yinxing (Folium Ginkgo) extract 123 decreased brain levels of the excitatory amino acids Glu and aspartate (Asp), and increased levels of the inhibitory amino acids γ-aminobutyric acid (GABA), taurine and glycine (Gly). Such a pattern seems to maintain the balance of inhibitory and excitatory amino acids in brain after I/R injury. TCM preparations, Chinese materia medica and active compounds have also been reported to influence the excitatory amino acid receptors. For example, TCM preparations such as Huanshaodan decoction 124 and Tianma Cuzhi granules 125 were found to reduce the N-methyl-D-aspartic acid (NMDA) receptor activity in both cerebral cortex and hippocampus. Single active components, such as sodium tanshione B 45 and senegenin 44 decreased NMDA receptor protein expression and mRNA levels of its NR2B subunit in hippocampus. The classical formula Buyang Huanwu decoction 126 decreased neurological deficit scores via down-regulating AMPA receptors, glutamate receptor-1 RNA and glutamate receptor-2 protein expression. In primary hippocampal neuron cultures, an active component flavonoid extract from Figure 1 Schematic summary of how the TCM preparation, Chinese materia medica and active compounds ameliorate I/R-induced cerebral microcirculatory disturbances, brain injury and neuron damage. TCM preparation, Chinese materia medica and active compounds inhibit I/R-induced multiple insults in cerebral microcirculation, including ROS outburst, inflammatory mediators overproduction, leukocyte infiltration, microvessel hyperpermeabilty, platelet aggregation, etc., leading to BBB disruption and capillary hypoperfusion, which culminate in ameliorating cerebral edema and/or brain hemorrhage, and brain injury. On the other hand, by improving cerebral microcirculation, together with anti-apoptosis, anti-excitoxicity and proneurogenesis effects, TCM preparation, Chinese materia medica and active compounds have potential to alleviate neurological deficits after I/R. BBB, blood brain barrier; EC, endothelial cell; H 2 O 2 , hydrogen peroxide; I/R, ischemia/reperfusion; MMPs, matrix metalloproteinases; NADPH, nicotinamide adenine dinucleotide phosphate; O 2 À , superoxide anion; OH À , hydroxyl radicals; ONOO À , peroxynitrite anion; ROS, reactive oxygen species, TCM, traditional Chinese medicine; XO, xanthine oxidase; ? denotes inhibition. Shishu (Diospyros kaki) leaves 127 and Yinxing (Folium Ginkgo) extract 128 protected neurons from Glu-or NMDA receptor-induced excitotoxicity. Also, microfluorometry showed that the Chinese materia medica Yinxing (Folium Ginkgo) extract decreased intracellular Ca 2þ concentrations in primary cultured hippocampal neurons treated with Glu 123 . In addition, injections of the TCM preparation Shenqi Fuzheng improved neuronal deficits, an effect which was suggested to be related to inhibition of Ca 2þ aggregation in brain 129 .
Effects of TCM on neurogenesis
Given that the proliferation of endogenous neuron stem cells and neurogenesis occurs in rodents 130 , as well as in primate 131 and patients 132 after ischemic stroke, pharmacological interventions related to neurogenesis are believed to be a key strategy to improve the neuron functions after cerebral I/R injury. TCM finds its role in this field as well. It was reported that the TCM preparation Tongxinluo capsule increased the number of nestinpositive neurons and VEGF mRNA expression in the rat subventricular zone and hippocampal subdentate gyrus zone of the ischemic hemisphere after MCAO, indicating a capacity of promoting differentiation and proliferation of the neural stem cells 133, 134 . In addition to VEGF, brain-derived neurotrophic factor (BNDF) 21, 22, 113 , basic fibroblast growth factor (bFGF) 135 and nerve growth factor (NGF) 13 may also be targets for the proneurogenic potential of some TCM preparations (e.g., Naoluo Xintong recipe 135 ), Chinese materia medica (e.g., Sanqi (Radix et Rhizoma Notoginseng) 113 ), and active components (baicalin 21, 22 and astragaloside 13 ). In an in vitro study, P. notoginseng saponins, active components extract from Sanqi (Radix et Rhizoma Notoginseng), was shown to promote rat hippocampal neural stem cells (NSC) proliferation and the expression of nestin/BrdU. mRNA levels of class III β-tublin (Tuj-1), vimentin, and nestin were also enhanced. Also, P. notoginseng saponins increased area density, optical density and numbers of nestin/BrdU, nestin/vimentin, and nestin/Tuj-1 positive NSC following OGD 136 . The TCM preparation Weinaokang preparation 137 and the single active component salvianolic acid B 42 , among others, were reported to improve neurogenesis and to promote the repair of ischemic areas.
Other neuroprotective mechanisms of TCM preparation, Chinese materia medica and active compounds
In addition to aforementioned mechanisms, TCM preparations, Chinese materia medica and active compounds are known to alleviate neuron damage after cerebral I/R indirectly via antioxidant, anti-inflammatory roles and promotion of capillary perfusion around neurons. For example, the classical formula oren-gedoku-to (Huanglian Jiedu Tang) lowered neuronal death by increasing the expression of Cu/Zn-SOD in the hippocampus of ischemic mice 138 . The TCM preparation Breviscapine injection (Dengzhanhuasu injection) 139 , and active compounds, such as total glycoside from Chishao (Radix Paeoniae Rubra) 53 and luteolin 31 , ameliorated neurological deficit and improved neuronal function through anti-oxidant actions as well. In addition, electron microscopic studies found that TCM preparations, such as Cerebralcare Granule s51,75 , Shexiang Xingnaonin preparation 102 and the single active compound apigenin 18 , exhibited a potential to decrease neurological scores and improve pathomorphology and neuron ultrastructure of ischemic cortex and hippocampal CA1 region after I/R. Suggested mechanisms for these effects include inhibition of cytokine production and platelet aggregation 102 , or promotion of capillary opening 51, 75 . Similarly, HE staining was used to show that the active compound baicalin increased neurons with pycnotic shape and condensed nuclei in cortex and hippocampus, effects which were related to suppression of NF-κB p65 activation 23 .
Summary
The present paper provides an overview of the ameliorating effects of compound TCM preparations, Chinese materia medica and active components on I/R-induced cerebral microcirculatory disturbances, brain injury and neuron damage, as summarized in Fig. 1 .
(1) Many studies demonstrated that compound TCM preparations, Chinese materia medica and their active components can ameliorate I/R-induced cerebral microcirculatory disturbances, including enhanced ROS production, release of cytokines/chemokines/adhesion molecules, leukocyte recruitment, microvessel hyperpermeability, BBB disruption and capillary hypoperfusion (Table 3) . (2) Compound TCM preparations, Chinese materia medica and their active components are capable of ameliorating I/Rinduced brain injury, such as brain infarction and perivascular edema. Such effects are attributable to beneficial actions on cerebral microcirculatory disturbances, together with attenuation of excitoxicity (Table 4) . (3) Compound TCM preparations, Chinese materia medica and their active components have the potential to alleviate neurological deficits and improve learning and memory capacity after I/R injury. Underlying mechanisms for these effects include inhibition of apoptosis, excitoxicity, oxidation and inflammation, along with stimulation of proneurogenesis (Table 5 ). (4) In spite of a number of clinical studies illustrating the ameliorating effects of TCM preparations, Chinese materia medica and active compounds on cerebral I/R-related diseases, strictly randomized, double-blind, placebo-controlled, and multicenter clinical trials remain to be conducted with large samples. More evidence-based data are required to confirm the effects of TCM preparation, Chinese materia medica and active compounds, especially Chinese classic formulas, on ischemic stroke in clinical studies. (5) Majority of the studies concerning the protective effects of TCM preparation, Chinese materia medica and active compounds on I/R-induced cerebral injury and neuron damage focus on ROS production, cytokine release, leukocyte recruitment and microvessel hyperpermeability. More attention should be paid to other microcirculatory insults, including platelet aggregation, mast cell degranulation, thrombus formation and lymphocyte activation. Furthermore, future studies should place more emphasis on mechanistic exploration in depth rather than merely descriptive observation.
For instance, what is the relationship between brain injury (especially cerebral microcirculatory disturbances) and delayed neuron damage? What are the initiating effector/receptor and specific signaling molecules for TCM preparations, Chinese materia medica and active compounds to regulate inflammatory responses, such as ROS production, cytokine release and leukocyte activation? Moreover, additional mechanisms that participate in ischemic brain injury and neuron damage should be addressed further in studying the role of TCM preparation, Chinese materia medica and active compounds in cerebral I/R injury. These energize metabolism, microglia activation, aquaporin molecules, and cyclic adenosine monophosphate (cAMP).
Ischemic stroke, post I/R-induced cerebral microcirculatory disturbances, subsequent brain injury, and neuron damage are complicated processes, and require interventions at multiple targets for successful treatment. TCM preparations and Chinese materia medica contain multiple active ingredients which been widely used for decades in the clinic as a potential therapeutic strategy for I/Rrelated cerebral diseases. Further clinical and experimental research is needed to understand their actions.
